• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习预测滥交悬崖。

Prediction of Promiscuity Cliffs Using Machine Learning.

机构信息

Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Endenicher Allee 19c, D-53115, Bonn, Germany.

出版信息

Mol Inform. 2021 Jan;40(1):e2000196. doi: 10.1002/minf.202000196. Epub 2020 Sep 29.

DOI:10.1002/minf.202000196
PMID:32881355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816223/
Abstract

Compounds with the ability to interact with multiple targets, also called promiscuous compounds, provide the basis for polypharmacological drug discovery. In recent years, a plethora of structural analogs with different promiscuity has been identified. Nevertheless, the molecular origins of promiscuity remain to be elucidated. In this study, we systematically extracted different structural analogs with varying promiscuity using the matched molecular pair (MMP) formalism from public biological screening and medicinal chemistry data. Care was taken to eliminate all compounds with potential false-positive activity annotations from the analysis. Promiscuity predictions were then attempted at the level of compound pairs representing promiscuity cliffs (PCs; formed by analogs with large promiscuity differences) and corresponding non-PC MMPs (analog pairs without significant promiscuity differences). To address this prediction task, different machine learning models were generated and the results were compared with single compound predictions. PCs encoding promiscuity differences were found to contain more structure-promiscuity relationship information than sets of individual promiscuous compounds. In addition, feature analysis was carried out revealing key contributions to the correct prediction of PCs and non-PC MMPs via machine learning.

摘要

具有与多个靶点相互作用能力的化合物,也称为混杂化合物,为多靶药物发现提供了基础。近年来,已经鉴定出了大量具有不同混杂性的结构类似物。然而,混杂性的分子起源仍有待阐明。在这项研究中,我们使用匹配分子对 (MMP) 形式从公共生物筛选和药物化学数据中系统地提取了具有不同混杂性的不同结构类似物。在分析中,我们特别注意从分析中排除所有具有潜在假阳性活性注释的化合物。然后尝试在代表混杂悬崖 (PC; 由具有较大混杂性差异的类似物组成) 和相应的非 PC MMP (没有显著混杂性差异的类似物对) 的化合物对水平上进行混杂性预测。为了解决这个预测任务,我们生成了不同的机器学习模型,并将结果与单个化合物的预测进行了比较。与单个混杂化合物相比,编码混杂差异的 PC 包含更多的结构-混杂关系信息。此外,通过机器学习进行了特征分析,揭示了正确预测 PC 和非 PC MMP 的关键贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/333d4d40ec52/MINF-40-2000196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/cabbf2177e75/MINF-40-2000196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/91c6cafffda9/MINF-40-2000196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/662c2cc4d916/MINF-40-2000196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/333d4d40ec52/MINF-40-2000196-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/cabbf2177e75/MINF-40-2000196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/91c6cafffda9/MINF-40-2000196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/662c2cc4d916/MINF-40-2000196-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b942/7816223/333d4d40ec52/MINF-40-2000196-g004.jpg

相似文献

1
Prediction of Promiscuity Cliffs Using Machine Learning.使用机器学习预测滥交悬崖。
Mol Inform. 2021 Jan;40(1):e2000196. doi: 10.1002/minf.202000196. Epub 2020 Sep 29.
2
Exploring structure-promiscuity relationships using dual-site promiscuity cliffs and corresponding single-site analogs.利用双位点混杂悬崖和相应的单点类似物探索结构混杂关系。
Bioorg Med Chem. 2020 Jan 1;28(1):115238. doi: 10.1016/j.bmc.2019.115238. Epub 2019 Nov 30.
3
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity.系统数据分析和诊断机器学习揭示具有单靶点和多靶点活性的化合物之间的差异。
Mol Pharm. 2020 Dec 7;17(12):4652-4666. doi: 10.1021/acs.molpharmaceut.0c00901. Epub 2020 Nov 5.
4
Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.计算化合物混杂分析的数据结构及其在人类激酶组抑制剂中的应用实例
J Comput Aided Mol Des. 2020 Jan;34(1):1-10. doi: 10.1007/s10822-019-00266-0. Epub 2019 Dec 2.
5
Activity profile relationships between structurally similar promiscuous compounds.结构相似的泛型化合物的活性谱关系。
Eur J Med Chem. 2013 Nov;69:393-8. doi: 10.1016/j.ejmech.2013.08.044. Epub 2013 Sep 12.
6
Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.小分子微阵列数据的匹配分子对分析确定了混杂峭壁,并揭示了极端化合物混杂性的分子起源。
J Med Chem. 2012 Nov 26;55(22):10220-8. doi: 10.1021/jm301292a. Epub 2012 Oct 22.
7
Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.系统计算鉴定由人类激酶组抑制剂形成的多功能性悬崖途径。
J Comput Aided Mol Des. 2019 Jun;33(6):559-572. doi: 10.1007/s10822-019-00198-9. Epub 2019 Mar 26.
8
Structure-Promiscuity Relationship Puzzles-Extensively Assayed Analogs with Large Differences in Target Annotations.结构-混杂性关系谜题——具有巨大靶点注释差异的广泛检测类似物
AAPS J. 2017 May;19(3):856-864. doi: 10.1208/s12248-017-0066-8. Epub 2017 Mar 6.
9
Analysis of Biological Screening Compounds with Single- or Multi-Target Activity via Diagnostic Machine Learning.基于诊断机器学习的单靶点或多靶点生物筛选化合物分析。
Biomolecules. 2020 Nov 27;10(12):1605. doi: 10.3390/biom10121605.
10
Rationalizing Promiscuity Cliffs.合理化混杂峭壁。
ChemMedChem. 2018 Mar 20;13(6):490-494. doi: 10.1002/cmdc.201700535. Epub 2017 Nov 6.

引用本文的文献

1
Tackling assay interference associated with small molecules.解决小分子相关的检测干扰问题。
Nat Rev Chem. 2024 May;8(5):319-339. doi: 10.1038/s41570-024-00593-3. Epub 2024 Apr 15.
2
Chemical toxicity prediction based on semi-supervised learning and graph convolutional neural network.基于半监督学习和图卷积神经网络的化学毒性预测
J Cheminform. 2021 Nov 27;13(1):93. doi: 10.1186/s13321-021-00570-8.

本文引用的文献

1
X-ray Structure-Based Chemoinformatic Analysis Identifies Promiscuous Ligands Binding to Proteins from Different Classes with Varying Shapes.基于 X 射线结构的化学信息学分析鉴定了与不同形状的不同类别蛋白质结合的多功能配体。
Int J Mol Sci. 2020 May 27;21(11):3782. doi: 10.3390/ijms21113782.
2
Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots.来自实验确定结构、结合构象和蛋白质家族依赖性相互作用热点的混杂配体。
ACS Omega. 2019 Jan 22;4(1):1729-1737. doi: 10.1021/acsomega.8b03481. eCollection 2019 Jan 31.
3
Selection of protein conformations for structure-based polypharmacology studies.
基于结构的多靶标药物研究中蛋白质构象的选择。
Drug Discov Today. 2018 Nov;23(11):1889-1896. doi: 10.1016/j.drudis.2018.08.007. Epub 2018 Aug 10.
4
Reconciling Selectivity Trends from a Comprehensive Kinase Inhibitor Profiling Campaign with Known Activity Data.将全面激酶抑制剂分析活动中的选择性趋势与已知活性数据进行协调。
ACS Omega. 2018 Mar 31;3(3):3113-3119. doi: 10.1021/acsomega.8b00243. Epub 2018 Mar 14.
5
UniProt: the universal protein knowledgebase.通用蛋白质知识库:UniProt
Nucleic Acids Res. 2018 Mar 16;46(5):2699. doi: 10.1093/nar/gky092.
6
Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited.进入药物化学的“大数据”时代:重新审视分子多配体性分析
Future Sci OA. 2017 Mar 6;3(2):FSO179. doi: 10.4155/fsoa-2017-0001. eCollection 2017 Jun.
7
Structure-Promiscuity Relationship Puzzles-Extensively Assayed Analogs with Large Differences in Target Annotations.结构-混杂性关系谜题——具有巨大靶点注释差异的广泛检测类似物
AAPS J. 2017 May;19(3):856-864. doi: 10.1208/s12248-017-0066-8. Epub 2017 Mar 6.
8
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
J Med Chem. 2017 Mar 23;60(6):2165-2168. doi: 10.1021/acs.jmedchem.7b00229. Epub 2017 Feb 28.
9
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
10
The ChEMBL database in 2017.2017年的ChEMBL数据库。
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. doi: 10.1093/nar/gkw1074. Epub 2016 Nov 28.